SAN JOSE, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and comp
Outset Medical, Inc. (NASDAQ:OM ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 7:00 AM EDT Company Participants Leslie Trigg - President, CEO & Chairman Renee Gaeta - CFO
Outset Medical allegedly misled investors on Tablo's FDA status, sales risks, and growth prospects, lacking a reasonable basis for its positive outlook.
Collaboration to provide patients and caregivers access to innovative home dialysis with the Tablo® Hemodialysis System Collaboration to provide patients and caregivers access to innovative home di
SAN JOSE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and comp
Outset Medical (OM) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estima
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Outset Medical, Inc. (NASDAQ:OM ) Q2 2025 Earnings Conference Call August 6, 2025 5:00 PM ET Company Participants James S. Mazzola - Head of Investor Relations Leslie L.
Outset Medical, Inc. (OM) came out with a quarterly loss of $0.84 per share versus the Zacks Consensus Estimate of a loss of $1.76. This compares to a loss of $7.05 per share a year ago.
Company raises 2025 revenue guidance to a range of $122 million to $126 million Company raises 2025 revenue guidance to a range of $122 million to $126 million

Outset Medical Names First Chief Nursing Officer

09:01am, Wednesday, 30'th Jul 2025
SAN JOSE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and comp
SAN JOSE, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and comp
The company's business model leverages recurring revenue streams and strong customer retention, supporting stable long-term growth. Key risks include potential regulatory changes and execution challen
Outset Medical (OM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term
SAN JOSE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and comp
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE